PMC:2940021 / 6328-7014 JSONTXT

Annnotations TAB JSON ListView MergeView

    0_colil

    {"project":"0_colil","denotations":[{"id":"20422195-18506712-60930","span":{"begin":490,"end":492},"obj":"18506712"},{"id":"20422195-17537635-60931","span":{"begin":494,"end":496},"obj":"17537635"},{"id":"20422195-16967365-60932","span":{"begin":498,"end":500},"obj":"16967365"},{"id":"20422195-18506712-60933","span":{"begin":678,"end":680},"obj":"18506712"},{"id":"20422195-16371549-60934","span":{"begin":682,"end":684},"obj":"16371549"}],"text":"Ultrasound applications are widely and routinely used in neuromuscular disorders in terms of assessment of changes in muscle morphology (atrophy, hypertrophy, changes in muscle architecture). In particular it is a useful screening tool during the initial diagnostic phase, especially in children. Depending on the disease entity, the sensitivity of detecting dystrophic changes ranges from 25% in non-dystrophic myopathies up to 100% in dystrophic myopathies (Duchenne muscular dystrophy) [10, 19, 20]. The detection of pathological changes can be helpful in guiding muscle biopsy, and the description of the muscle involvement pattern might help in the differential diagnosis [10, 21]."}

    2_test

    {"project":"2_test","denotations":[{"id":"20422195-18506712-29368014","span":{"begin":490,"end":492},"obj":"18506712"},{"id":"20422195-17537635-29368015","span":{"begin":494,"end":496},"obj":"17537635"},{"id":"20422195-16967365-29368016","span":{"begin":498,"end":500},"obj":"16967365"},{"id":"20422195-18506712-29368017","span":{"begin":678,"end":680},"obj":"18506712"},{"id":"20422195-16371549-29368018","span":{"begin":682,"end":684},"obj":"16371549"}],"text":"Ultrasound applications are widely and routinely used in neuromuscular disorders in terms of assessment of changes in muscle morphology (atrophy, hypertrophy, changes in muscle architecture). In particular it is a useful screening tool during the initial diagnostic phase, especially in children. Depending on the disease entity, the sensitivity of detecting dystrophic changes ranges from 25% in non-dystrophic myopathies up to 100% in dystrophic myopathies (Duchenne muscular dystrophy) [10, 19, 20]. The detection of pathological changes can be helpful in guiding muscle biopsy, and the description of the muscle involvement pattern might help in the differential diagnosis [10, 21]."}

    TEST0

    {"project":"TEST0","denotations":[{"id":"20422195-193-199-60930","span":{"begin":490,"end":492},"obj":"[\"18506712\"]"},{"id":"20422195-197-203-60931","span":{"begin":494,"end":496},"obj":"[\"17537635\"]"},{"id":"20422195-201-207-60932","span":{"begin":498,"end":500},"obj":"[\"16967365\"]"},{"id":"20422195-175-181-60933","span":{"begin":678,"end":680},"obj":"[\"18506712\"]"},{"id":"20422195-179-185-60934","span":{"begin":682,"end":684},"obj":"[\"16371549\"]"}],"text":"Ultrasound applications are widely and routinely used in neuromuscular disorders in terms of assessment of changes in muscle morphology (atrophy, hypertrophy, changes in muscle architecture). In particular it is a useful screening tool during the initial diagnostic phase, especially in children. Depending on the disease entity, the sensitivity of detecting dystrophic changes ranges from 25% in non-dystrophic myopathies up to 100% in dystrophic myopathies (Duchenne muscular dystrophy) [10, 19, 20]. The detection of pathological changes can be helpful in guiding muscle biopsy, and the description of the muscle involvement pattern might help in the differential diagnosis [10, 21]."}

    MyTest

    {"project":"MyTest","denotations":[{"id":"20422195-18506712-29368014","span":{"begin":490,"end":492},"obj":"18506712"},{"id":"20422195-17537635-29368015","span":{"begin":494,"end":496},"obj":"17537635"},{"id":"20422195-16967365-29368016","span":{"begin":498,"end":500},"obj":"16967365"},{"id":"20422195-18506712-29368017","span":{"begin":678,"end":680},"obj":"18506712"},{"id":"20422195-16371549-29368018","span":{"begin":682,"end":684},"obj":"16371549"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Ultrasound applications are widely and routinely used in neuromuscular disorders in terms of assessment of changes in muscle morphology (atrophy, hypertrophy, changes in muscle architecture). In particular it is a useful screening tool during the initial diagnostic phase, especially in children. Depending on the disease entity, the sensitivity of detecting dystrophic changes ranges from 25% in non-dystrophic myopathies up to 100% in dystrophic myopathies (Duchenne muscular dystrophy) [10, 19, 20]. The detection of pathological changes can be helpful in guiding muscle biopsy, and the description of the muscle involvement pattern might help in the differential diagnosis [10, 21]."}